• Molecular NameCarbetocin
  • SynonymCarbetocino [inn-spanish]; Carbetocinum [inn-latin]
  • Weight988.178
  • Drugbank_IDDB01282
  • ACS_NO37025-55-1
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-1.16
  • pkaN/A
  • LogD (pH=7, predicted)-1.16
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.47
  • LogSw (predicted, AB/LogsW2.0)0.73
  • Sw (mg/ml) (predicted, ACD/Labs)3.33
  • No.of HBond Donors13
  • No.of HBond Acceptors23
  • No.of Rotatable Bonds18
  • TPSA387.81
  • StatusFDA approved
  • AdministrationIntravenous, intramuscular
  • PharmacologyAn obstetric drug used to control postpartum hemorrhage, bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin, such as contraction of the uterus.
  • Absorption_valueN/A
  • Absorption (description)Bioavailability is 80% following intramuscular injection.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life40 min
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A